Esperion Therapeutics, Inc. (ESPR)
NASDAQ: ESPR · Real-Time Price · USD
1.410
-0.030 (-2.08%)
At close: Apr 1, 2025, 4:00 PM
1.390
-0.020 (-1.39%)
After-hours: Apr 1, 2025, 4:05 PM EDT

Esperion Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2015
Period Ending
Apr '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2015
Market Capitalization
279433340459306725
Upgrade
Market Cap Growth
27.49%27.49%-25.93%49.97%-57.77%-55.52%
Upgrade
Enterprise Value
718848757815726687
Upgrade
Last Close Price
1.442.202.996.235.0026.00
Upgrade
Forward PE
-16.60----
Upgrade
PS Ratio
0.811.302.926.083.903.19
Upgrade
PB Ratio
-0.70-1.11-0.75-1.42-1.55-7.54
Upgrade
EV/Sales Ratio
2.162.556.5110.799.263.02
Upgrade
EV/EBITDA Ratio
13.1915.58----
Upgrade
EV/EBIT Ratio
13.2115.59----
Upgrade
Debt / Equity Ratio
-1.52-1.52-1.19-1.56-2.63-3.77
Upgrade
Debt / EBITDA Ratio
10.2910.29----
Upgrade
Asset Turnover
1.211.210.510.240.210.80
Upgrade
Inventory Turnover
1.431.432.574.194.76-
Upgrade
Quick Ratio
0.910.910.842.173.853.37
Upgrade
Current Ratio
1.371.371.292.674.493.68
Upgrade
Return on Assets (ROA)
12.37%12.37%-42.86%-35.64%-36.31%-26.73%
Upgrade
Return on Capital (ROIC)
23.58%23.58%-72.90%-44.78%-45.52%-36.13%
Upgrade
Return on Capital Employed (ROCE)
55.70%55.70%----
Upgrade
Earnings Yield
-19.02%-11.94%-61.54%-50.90%-87.91%-19.81%
Upgrade
FCF Yield
-8.81%-5.53%-39.85%-38.09%-86.18%-11.87%
Upgrade
Buyback Yield / Dilution
-81.54%-81.54%-55.26%-129.76%-5.20%-1.42%
Upgrade
Updated Mar 7, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q